CTLA4 and nasopharyngeal carcinoma: The average abundance of CTLA4+ Tregs is approximately 20%, which might explain why NPC is responsive to anti-CTLA4 drugs that relieve Treg-mediated suppression and expedite proliferation of effector T cells (23).